Introduction
Several milestones have marked the successful introduction and implementation of Intuitive Surgical robotic systems in the field of laparoscopic surgery [1, 2] . In 1999, the company started first studies in cardiac surgery, in parallel to their competitor Computer Motion [3, 4] . Robot-assisted laparoscopic radical prostatectomy was pioneered in 2001, and Intuitive Surgical acquired Computer Motion in 2004 [5] [6] [7] [8] [9] [10] . After successful US Food and Drug Administration (FDA) regulatory approvals, four generations of the da Vinci system have been introduced over the last 17 years [10] [11] [12] [13] [14] [15] . In 2016, installations of da Vinci have risen by 21% to >2500 units worldwide, and robotic procedures leaped by 25% to >450 000, mainly performed in urology, gynaecology and visceral surgery [16] .
Intuitive Surgical currently owns >1500 patents (Appendix 1). Several manufacturers are developing alternative robotic systems ( Figs 1-8) ; however, because of issues related to patenting, in particular, their clinical applications remain limited [17] [18] [19] [20] [21] [22] . Nevertheless, the landscape of robotic surgery is expected to witness significant changes as new technologies might soon become available.
The aim of the present study was to provide a comprehensive overview of the current status of robotic systems for urological surgery with a special emphasis on the development of novel devices and their potential future clinical applicability.
Materials and Methods
A comprehensive literature review was performed using the PubMed/Medline electronic search engine. The following search terms were used: 'robotic surgical device (n = 665)', 'new surgical robots (n = 186)', 'tele-presence surgery (n = 112)', 'robotic surgery AND urology (n = 2564)', 'robotic single port surgery (n = 821)', 'ZEUS robotic (n = 111)', 'Da Vinci XI (n = 102)'.
Existing patents for robotic surgical devices were searched for using the Google search engine (www.google.com/patents; Appendices 1 and 2). Retrieved patents were classified according to their relevance in terms of clinical applicability.
Robotic master-slave systems consist of a console unit and a patient cart at bedside [1, 15] . To faciliate illustration and comparison of the different systems, we considered the following main technical features ( (single arms attached to the table, single arms on cart, multiple arms on a single cart); (3) camera control (voice control, eye-tracking, hand-controlled); (4) special features (haptics, lightweight arms, versatile use of camera); and (5) purpose built platforms for robotic single-port surgery. Table 1 summarizes the main historical developments of robotic technology in urological surgery.
Historical Developments of Robotic Systems in Urology

Early Years
Artemis
In 1996, Buess and Schurr successfully performed a telesurgical laparoscopic porcine cholecystectomy with the ARTEMIS system, designed with an open console and three single arms. The surgeon used polarizing glasses for threedimensional (3D) video-endoscopy (Fig. 1) . Patents for this system were registered in 1997 and 2002, but, despite promising experimental trials in abdominal and cardiac surgery, it was never used during a clinical case [23] [24] [25] . All existing patents have expired (Appendix 1).
Zeus
Computer Motion Inc. (USA) developed the voice-controlled camera arm AESOP, together with the ZEUS system, enabling even long-distance manipulation. Production and development of ZEUS and AESOP were stopped when Intuitive Surgical acquired Computer Motion in 2004.
The ZEUS system was designed with a control unit and two single arms plus the voice-controlled camera arm AESOP mounted to the operating table (Fig. 6A ). The surgeon sat at an open console on a high-backed chair with armrests, controlling the instrument with chopsticklike handles (Fig. 3A) . The instruments provided only 4 degrees of freedom (df). A two-dimensional (2D) or 3D video system was used for visualization of the operating field.
All relevant patents for this system were registered in 1999 (Appendix 1 and Table 1) , and a Conformit e Europ eene (CE) mark and FDA approval were received in 1999 for cardiovascular surgery [4] .
The most impressive demonstration of this system was the transatlantic laparoscopic cholecystectomy performed by Marescaux et al. [26] . There were only few human urological applications of the ZEUS system, such as pelvic lymph node dissection and pyeloplasty [27, 28] . A National Aeronautics and Space Administration (NASA) project on telepresence battlefield surgery led to the development of the da Vinci â System (Intuitive Surgical, Sunnyvale, CA, USA) [29, 30] . The design of this system was a closed console offering a 3D video system with in-line view ( Fig. 2A) . Three robotic arms were mounted on a cart. The da Vinci S provided better range of motion, longer robotic arms, implementation of bipolar energy, and an optional highdefinition (HD) video system or a fourth arm (Table 1) [11, 12] .
The unique features of this system were its Endowrist â technology with 6 df and loop-like handles enabling ergonomic working, including a clutch mechanism (Fig. 4A) . Patents regarding open telepresence surgery dated back to 1994 (3D mirror technology), and all relevant patents were registered in 1999 (Appendix 1 and Table 1 ). In 2015, Intuitive Surgical abandoned technical support for the da Vinci 2000. Although recent patents were registered in 2007 (Appendix 1), technical support for da Vinci S will end in 2018.
The da Vinci system has had a CE mark since 1999 and full FDA approval since 2001.
It was designed for robot-assisted coronary artery surgery, and the first cases were performed at the Heart Centre of Leipzig [3] . In 2001, robot-assisted radical prostatectomy started in Europe [1, [5] [6] [7] [8] . Menon et al. [9] established the first full-working clinical programme.
Da Vinci Si
In 2009, the da Vinci Si system was launched with full CE mark and FDA approval. Its unique features were HD video technology, finger-based clutch mechanism and isocyanine green fluorescence (Fire-Fly TM technology) [13, 14] . The da Vinci Si dual console allows two surgeons to collaborate during surgery, representing an ideal training platform (Fig. 2B) , as proposed already in 2000 by Autschbach et al. [31] . The da Vinci Si system also allows use of the VeSPA system for robotic single-port surgery, providing instruments with only 4 df [32] .
Da Vinci Xi
In 2014, Intuitive Surgical introduced the da Vinci Xi system with CE mark and FDA approval (Fig. 5A ). Its unique features were its 8-mm 3D HD camera to be chosen liberally at all four ports ('camera hopping'). This feature can be important for specific mutiquadrant procedures, such as colorectal surgery. The robotic arms have a much finer design to minimize instrument clashing, and the operating table can be moved while the robotic arms are connected ('table motion' technology). With this system, the new robotic SP 1098 platform for robotic single-port surgery with 6 df can be used (Fig. 7A) [15] . Recent technological advancements include stapling devices with 6 df, or 6-df flexible instruments for the VeSPa single-port system.
Abandoned Projects
SR1
In 2009, Kyung Hee developed the SR1 at Seoul Yonsei University in collaboration with Samsung, consisting of two industrial robots (AS2, Samsung Automation, Korea) with 6 df and force feedback mounted at bedside with a 2D standard laparoscope. Featuring a relatively simple design, this system allowed telesurgery, similar to the ZEUS system, but it was never used clinically [18] .
Amadeus
In 2012, the Amadeus RSS (Titan Medical, Toronto, Canada) was presented on an experimental level and patented (Appendix 1 and Table 2 ). The device had similarities to the da Vinci design, with a closed console and three robotic arms aligned on a curved support (Fig. 5B) [21] . Titan Medical stopped development of the Amadeus RSS in 2013, and the system therefore never came to market.
Commercially Available Alternatives to da Vinci
Telelap ALF-X Supported by the European Commission, the Italian healthcare company Sofar (Milan, Italy) developed an alternative robotic system, the Telelap ALF-X. The design featured a remote control station and three robotic arms mounted on three separate carts (Fig. 6D) . The device uses an open console with a 3D HD screen requiring polarized glasses (Fig. 3C ). Two handles similar to laparoscopic hand-pieces manipulate 4-df and 6-df instruments attached to the robotic arms (Fig. 4D ). Tuebingen Scientific (T€ ubingen, Germany) developed instruments based on Radius technology [33] . The system's unique features include haptic feedback and an eye-tracking system. Haptic feedback is realized by countermovements of the laparoscopic handle at the console according to force and direction applied at the tip of the instrument [34] . The eye-tracking system controls camera movements; for example, the image is zoomed, when the surgeon's head approaches the screen [35] .
An initial patent was registered in 2007 (Appendix 1 and Table 1 ). In 2015, TransEnterix (Morrisville, NC, USA) acquired Sofar Surgical Robotics [36] , and later a patent for 6-df instruments from Tuebingen Scientific (Appendix 1).
Telelap ALF-X has had a CE mark since 2016 for indications in general surgery, gynaecology, urology and thoracic surgery. TransEnterix is preparing a submission for FDA clearance. With regard to the clinical application of this system, early clinical reports of robot-assisted hysterectomies were published in 2016 [37, 38] , and the first devices have been sold in Italy.
Upcoming Robotic Systems: Ongoing Projects
Medtronic
In 2010, experimental results of MiroSurge (German Aerospace Centre, Oberpfaffenhofen, Germany) were published [39, 40] . In 2013, Covedien (Dublin, Ireland) acquired the licence for its commercial use, and included further developments in their two research and development centres in the USA [41] . Since Medtronic completed the acquisition of Covidien in 2015, the company became able to develop all necessary instruments [42] , and it is currently working on the 10th prototype of this system. MiroSurge consisted of three lightweight arms mounted on the operating table, and an open console with the surgeon sitting in front of an autofocusing monitor (Fig. 3B) . The robotic arms are composed of seven joints with serial kinematics, comparable to human arms. Instruments are driven by micro-motors (Fig. 6B) , optionally providing tactile feedback via potentiometers.
Patents were registered in 2012 and 2013 (Appendix 1 and Table 2 ). Medtronic plans to initiate clinical trials in India and to launch the device in the USA in 2018 [42] .
Avatera
Since 2012, Avateramedical (Jena, Germany) have been developing Avatera in cooperation with Force Dimension (Nyon, Switzerland), for transmission of handle movements at the console to the robotic arms, and with Tuebingen Scientific (T€ ubingen, Germany) for 6-df-instruments. It features a closed console with an integrated seat using a microscope-like technology for in-line 3D image with full HD resolution (Fig. 2C) . Four robotic arms are mounted on a single cart (Fig. 5C ), and 6-df instruments with a diameter of 5 mm are applied.
Patents were registered in 2012 and 2013 (Appendix 1 and Table 2 ). The system has only been used in experimental animal trials. The validation process for CE certification was initiated in 2017.
Revo-i
In collaboration with Yonsei University and other Korean academic and industry groups, Meerecompany (Hwasong, Korea) designed the REVO-I platform, featuring an open console (Fig. 3D ) and a four-arm system mounted on a single cart (Appendix 1, Table 2 and Fig. 5D ). The system uses 6-df instruments with a diameter of 8 mm.
The patent was registered in 2014 (Appendix 1 and Table 2 ). In 2016, the first results of animal studies were published [19, 20] , and approval for human trials in South Korea was received [22, 43] .
Medicaroid
Matsuda recently reported details of the Japanese Robot during the 2016 AUA meeting [22] . In 2016, Medicaroid (Kobe, Japan) started a corporation in Silicon Valley to develop the US market for made-in-Japan medical robots using the research and development and manufacturing capabilities of Sysmex and Kawasaki [44] .
The device consists of three robotic arms attached to the operating table and a semi-closed console using a microscope-like ocular lens, but still requires polarized (Fig. 2D) . Human trials are expected in Japan in 2018.
Verb Surgical
Verb Surgical was formed in 2015 as independent start-up company, backed by Google and Johnson & Johnson to harness the unique capabilities of both companies [45]. To date, there has been no detailed information available about the design of their robotic system [46].
Experimental Devices
Raven
The Raven Project (Universities of Santa Cruz, Berkeley, Davis) aims to produce an open-source system that would allow two surgeons to operate on a single patient simultaneously. The initial systems included two portable surgical robotic arms, each offering 7 df and a portable surgical console [47] . Raven III offers four robotic arms and optionally two cameras. Raven III is one of the most advanced surgical robotics research platforms, focused on battlefield and underwater remote surgery.
Sofie
The SOFIE (Surgeon's Operating Force-feedback Interface Eindhoven) includes two components (master and slave) completely separate from each other. Communication takes place over data cables arranged in an overhead-wiring boom [48] . Three different lightweight robotic arms with a maximum of 8 df are mounted on the operating table. To date, no laparoscopic application of SOFIE has been published.
Robotic Systems for Single-Port/Single-Site Surgery
Console-Based Devices
Laparo-endoscopic single-site surgery (LESS) further minimizes access trauma of classic laparoscopic or robotassisted laparoscopic surgery as a potential step toward true natural orifice surgery. The classic LESS technique is significantly impaired, however, by suboptimal ergonomics with clashing of instruments. The VesPA system provides only 4-df instruments. Updated robotic technology may overcome these limitations (Fig. 7) .
SP 1098
The da Vinci Xi system also allows the use of the robotic single-port SP 1098 platform (Fig. 7A , Appendix 2 and Table 3 ), including a 3D HD flexible telescope and three The system has had a CE mark since 2012 and FDA approval is in preparation. The SP 1098 platform has been used in clinical pilot studies in France, focusing on robot-assisted single-port partial nephrectomy, radical prostatectomy and perineal prostatectomy [16, 49, 50] .
SPORT TM
After the unsuccessful introduction of the Amadeus RSS, Titan Medical focused on the SPORT Surgical System as a platform for robotic LESS.
SPORT has an open console with 3D HD vision controlling a 3D flexible telescope with fibre-optic based illumination and two flexible instruments (Appendix 2, Table 3 and Fig. 7B ) [21, 51] .
The first public demonstration of SPORT was realized at SAGES 2016 in Boston. FDA approval for the system is pending [52] . Its main application is expected to be LESS cholecystectomy. Recently, robotic single-port partial nephrectomy was performed in animal models requiring additional trocars for retraction.
Experimental Devices
The ARAKNES project (Array of Robots Augmenting the Kinematics of Endoluminal Surgery) was funded by European Union programme to produce a micro-robotic-based smart operating system for advanced endoscopic surgery [53] . The system (SPRINT robot) is based on the common design of a remote console and two robotic arms with rotating endeffectors (Fig. 7D ).
The IREP (Insertable Robotic Effectors Platform) was developed at Vanderbilt University. It consists of a 3D telecope and two flexible arms with a snake design providing a passive and active segment. Enlargement of the working space may be provided based on parallelogram instrument design (Fig. 7C) . The device is operated by two hand-pieces and a 2D monitor not comparable to a surgical console [54] .
Bedside-Based Devices
SurgiBot
The Spider System (TransEnterix) represents a platform developed for LESS based on tubes in which flexible instruments can be manipulated. The initial device used wirebased manipulators only for 5-mm instruments, requiring insertion of on additional trocar for ablative renal surgery [55] . Handling of instruments was difficult, particularly concerning endoscopic suturing. TransEnterix improved the system considerably by providing the robotic-arm SurgiBot.
The Spider system includes a bedside platform with multiple features, such as triangulation adjustment, multi-quadrant movement, robotic lateral movement and rotation, clutch of instruments in an ergonomic position, and a 3D HD video system (Table 4 and Fig. 8 ).
In 2015, TransEnterix submitted an application for FDA approval [56] .
LODEM
A flexible locally operated end-effector manipulator (LODEM) was developed for single-site laparoscopic surgery at Osaka Institute of Technology, Japan. The device uses crank-slider and cable-rod mechanisms to achieve 5 df. The surgeon uses a robotic arm for endoscope and forceps, together with standard laparoscopic instruments [57] .
The device has been tested in vitro and in vivo for surgical indications.
Bedside-Based Devices For Laparoscopy
MIM System
The manually manipulated robot-like system MIM was developed at the Universiy of Utrecht and is an interesting modification of bedside devices for laparoscopic surgery providing 7 df [58] .
This device enables instrument movement similar to the da Vinci systems based on a parallelogram design; specific instruments (i.e. bipolar forceps) have not yet been developed. The device has been tested only experimentally. Recently, Lapara Surgical (www.nlc.nl/lapara-surgical) was founded to launch the system clinically in 2019 (J. Jaspers, personal communication).
ETHOS Plus Motorized 6-df Instruments
The ETHOS TM chair (Ethos, Seattle, WA, USA) avoids the torero position during pelvic surgery because the surgeon sits over the patient's head rather than standing or sitting laterally. In combination with motorized instruments offering 6 df, such as the DEX robot (Dexterit e, Annecy, France) or the Kymerax (Karl Storz, Tuttlingen, Germany) systems, and with 3D HD video technology, the ergonomics of laparoscopy can be significantly improved [59] [60] [61] [62] .
The surgeon has two adjustable armrests and footrests with integrated foot switches enabling electrically motorized All devices have a CE mark and the ETHOS chair is FDAapproved.
Compared with robotic systems using a console, the design solutions of the ETHOS chair are much cheaper (<100 000 Euro). They may compensate for the deficiencies of laparoscopy, particularly during reconstructive surgery; however, the system still lacks a clutch mechanism.
Robotic Devices for Retrograde Intra-Renal Surgery
Avicenna Roboflex
Robotic master-slave systems are not limited to laparoscopic surgery [63] . Recently, the Avicenna Roboflex (Elmed, Ankara, Turkey) was introduced to perform retrograde intrarenal surgery.
The surgeon sits at an open console manipulating a standard flexible ureteroscope with HD video technology. The handpiece of the scope is attached to a robotic manipulator enabling rotation, insertion and deflexion of the scope. All movements can be graduated and fine-tuned. Irrigation, activation and control of the laser fibre as well as fluoroscopy are provided by touch-screen functions and foot pedals.
The Avicenna Roboflex has had a CE mark since 2014, and FDA approval is in preparation.
The first multi-centric experiences of the Avicenna Roboflex are promising [64] .
Discussion
Over the last 15 years, Intuitive Surgical has built high barriers to new entry of surgical robots by superior product offerings, intellectual property protection, multiple regulatory clearances, a large installation base, worldwide training centres, strong customer relationships, and an excellent balance sheet [65] . Expiry of existing key patents in 2019 may soon change this status quo, and stimulate a new era of robotic master-slave systems. In Europe and Asia several devices are under development, and the Telelap ALF-X has already received a CE mark [37, 38] ; however, FDA approval still represents a significant challenge [66] .
Recent internet publications have emphasized earlier expiry of Intuitive Surgical's key patents [65, 67] ; however, we identified only a few 1994 patents related to construction of a console for battlefield surgery. All relevant patents of ZEUS and Da Vinci were listed in 1999 and thus will expire in 2019 (Appendix 1). Accordingly, TransEnterix will focus on first studies in Europe, Meerecompany has approval for human studies in Korea, and Avateramedical aims to have the first CE mark to enter the European market.
In summary, we will see further devices being introduced clinically worldwide in the next 2 years. FDA approval for such systems, however, can be expected in 2019 at the earliest.
Several modifications of master-slave systems have been introduced (Table 4 and Figs 2-7) . Intuitive Surgical and Avateramedical rely on the principle of a closed console with in-line 3D video technology, whereby the surgeon is immersed in the operative field and does not need to use polarized glasses, which are associated with loss of brightness (Fig. 2) . The advantages of an open console include better contact with the team at bedside and the flexibility of such systems to integrate future technologies (Fig. 3) . Ultra-HD (4K) video technology features larger screens and higher resolution, whereas full HD 3D screens are already used in the entertainment industries [59] .
Computer Motion started with a voice-controlled camera system (AESOP), whereas Intuitive Surgical introduced navigation of telescopes by two handles. Both instruments are thereby kept at optimum distance to the telescope, thus enabling immediate continuation of the next surgical step. Sofar-TransEnterix have developed an eye-tracking system to control the telescope. All indirect camera controls (based on voice, head-moves, eye-tracking) have the risk of inadvertent movements or malfunction [59] .
Fingertip-based controls of instruments use the index finger and thumb, similarly to forceps (Fig. 4) . Laparoscopic handles control instruments by thumb and middle finger allowing the index finger to be used for further functions (activation of haptic feedback, rotation of instrument) and enable the use of 4-df instruments (Ligasure TM , staplers, graspers). To date, haptic feedback has been realized only for laparoscopic handles; however, only fingertip-based controls allow intuitive wrist-controlled movements, which are most relevant during endoscopic suturing. The ZEUS system used three robotic arms individually mounted on the operating table (Fig. 6A) , but, for a fourth arm, the space was limited. The same limitation can occur when each arm is mounted on a cart (Fig. 6D) . Conversely, individual arrangement of robotic arms is more versatile compared with a four arm-arrangement on a single cart (Fig. 5) .
The clutch mechanism is important for robot-assisted surgery. Clutching is usually activated via a foot pedal. The da Vinci Si features a fingertip-based clutch function for each instrument, which may be in conflict with standard instrument moves. Thus, some surgeons disable this function to prevent inadvertent finger clutching. Only bedside devices with clutch functions (i.e. SurgiBot) may have a potential for widespread clinical use.
Intuitive Surgical entirely developed and manufactured the da Vinci system, while the 3D video technology and specific instruments (stapler, harmonic scalpel, vessel sealer) required collaborations with other companies. By contrast, joint ventures seem to play an important role for the development of upcoming robots: force dimension dominates transmission of fingertip-based movements on robotic end-effectors (Fig. 4) [63, 68] . Tuebingen Scientific is involved in the production of 6-df instruments [56] . In order to develop its robotic system, Medtronic combined the German robotic technology with the know-how of Covidien on laparoscopic instruments [41,42].
As new players will soon come into the market, costs are expected to be lower [65] ; however, none of the companies competing with Intuitive Surgical have obtained FDA approval yet. Indeed, the variety of new devices will have an impact on the costs, including purchase and maintenance of the robot as well as instrument prices. Upcoming devices will have to address the following issues, in order of relevance: (1) clinical outcomes; (2) FDA regulatory approval; (3) marketing development; and (4) patent approval and protection. In this scenario, cheaper bedside solutions may also represent a valid option [59] [60] [61] .
The development of robotic technology will never stop. Next-generation devices might offer novel distinct features, such as haptic gloves or cellular image guidance. For example, cooperation of Google and Johnson & Johnson aims to use cellular-guided imaging in their robot [46, 47] . Shademan et al. [69, 70] have described in vivo supervised autonomous soft tissue surgery in an open surgical setting, enabled by a plenoptic 3D and near-infrared fluorescent imaging system that supports an autonomous suturing algorithm. Based on expert human surgical practices, a computer program generates a plan to complete complex surgical tasks on deformable soft tissue, such as suturing an intestinal anastomosis [69, 70] . Despite dynamic scene changes and tissue movement during surgery, they could show that the outcome of supervised autonomous procedures was superior to surgery performed by expert surgeons and robot-assisted techniques [70] . STAR (Smart Tissue Autonomous Robot) results show the potential for autonomous robots to improve efficacy, consistency, functional outcome, and accessibility of surgical techniques [70] . Similarly, robot-assisted water-jet ablation (Procept, Redwood Shores, CA, USA) had significantly better ablation efficacy compared with standard transurethral resection [71] .
Conclusions
Several console-based robots for laparoscopic multi-and single-port surgery are expected to come to market within the next 5-10 years. Certainly, the high technical standards of four da Vinci generations have set a high bar for upcoming devices. New platforms will need to be critically assessed, and their performance necessarily compared with the current 'gold standard' da Vinci. Ultimately, the implementation of these new systems will depend on their actual clinical applicability and costs. How these developments will facilitate surgeons and whether their use will translate into better outcomes for our patients remains to be determined.
After 15 years, robotic technology has gained an established and irreversible role in urological laparoscopic surgery, and it might start playing a role also in other areas of urology, as demonstrated by the recent introduction of robot-assisted flexible ureterorenoscopy. We have already entered the era of robotic minimally invasive surgery, and it is our responsibility to stay tuned as we witness ongoing developments in this fascinating technology-driven field of research.
